Cargando…
Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition
Histone deacetylase 3 (HDAC3) has an oncogenic role in apoptosis and contributes to the proliferation of cancer cells. MI192 is a novel HDAC3-specific inhibitor that displays antitumor activity in many cancer cell lines. However, the role of HDAC3 and the antitumor activity of its inhibitor MI192 ar...
Autores principales: | Yin, Yuyao, Zhang, Mingming, Dorfman, Robert Gregory, Li, Yang, Zhao, Zhenguo, Pan, Yida, Zhou, Qian, Huang, Shan, Zhao, Shimin, Yao, Yuling, Zou, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520875/ https://www.ncbi.nlm.nih.gov/pubmed/28569784 http://dx.doi.org/10.1038/cddis.2016.457 |
Ejemplares similares
-
Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2
por: Zhang, Mingming, et al.
Publicado: (2017) -
Down-regulation of HDAC3 inhibits growth of cholangiocarcinoma by inducing apoptosis
por: Zhang, Mingming, et al.
Publicado: (2017) -
Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosis
por: Zhang, Mingming, et al.
Publicado: (2019) -
Correction to: Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosis
por: Zhang, Mingming, et al.
Publicado: (2019) -
The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming
por: Xu, Lei, et al.
Publicado: (2019)